The Manufacturers Life Insurance Company purchased a new stake in Delek US Holdings, Inc. (NYSE:DK – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 30,698 shares of the oil and gas company’s stock, valued at approximately $1,560,000.
A number of other institutional investors and hedge funds also recently modified their holdings of DK. Vanguard Group Inc. boosted its stake in shares of Delek US by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 6,330,858 shares of the oil and gas company’s stock worth $187,773,000 after acquiring an additional 38,577 shares in the last quarter. Williamson Legacy Group LLC acquired a new stake in shares of Delek US during the fourth quarter worth $1,095,000. Healthcare of Ontario Pension Plan Trust Fund raised its position in shares of Delek US by 1,173.2% during the fourth quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 954,900 shares of the oil and gas company’s stock worth $28,322,000 after purchasing an additional 879,900 shares during the period. Y Intercept Hong Kong Ltd lifted its holdings in shares of Delek US by 281.5% during the first quarter. Y Intercept Hong Kong Ltd now owns 45,471 shares of the oil and gas company’s stock valued at $2,049,000 after purchasing an additional 33,553 shares during the last quarter. Finally, Bank of America Corp DE lifted its holdings in shares of Delek US by 118.0% during the first quarter. Bank of America Corp DE now owns 846,204 shares of the oil and gas company’s stock valued at $38,138,000 after purchasing an additional 458,004 shares during the last quarter. Institutional investors and hedge funds own 97.01% of the company’s stock.
Delek US Stock Performance
Shares of Delek US stock opened at $71.95 on Friday. Delek US Holdings, Inc. has a 12 month low of $25.85 and a 12 month high of $77.40. The company has a quick ratio of 0.47, a current ratio of 0.76 and a debt-to-equity ratio of 7.53. The stock has a market cap of $4.41 billion, a PE ratio of 20.21, a price-to-earnings-growth ratio of 1.42 and a beta of 0.59. The business has a fifty day simple moving average of $62.97 and a 200-day simple moving average of $49.91.
Delek US Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Monday, August 10th. Stockholders of record on Monday, August 3rd were issued a $0.255 dividend. The ex-dividend date was Monday, August 3rd. This represents a $1.02 dividend on an annualized basis and a dividend yield of 1.4%. Delek US’s dividend payout ratio is currently 28.65%.
Insider Buying and Selling
In other news, Director William Finnerty sold 5,000 shares of the stock in a transaction that occurred on Monday, June 29th. The shares were sold at an average price of $51.50, for a total value of $257,500.00. Following the completion of the sale, the director directly owned 34,805 shares of the company’s stock, valued at $1,792,457.50. This represents a 12.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Reuven Spiegel sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $68.21, for a total transaction of $682,100.00. Following the sale, the executive vice president owned 36,435 shares of the company’s stock, valued at approximately $2,485,231.35. This represents a 21.54% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 153,645 shares of company stock worth $10,248,392 over the last ninety days. 3.56% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
A number of equities analysts recently weighed in on DK shares. TD Cowen lifted their price target on Delek US from $58.00 to $76.00 and gave the stock a “buy” rating in a research note on Tuesday, July 21st. Citigroup reaffirmed a “neutral” rating on shares of Delek US in a research note on Thursday, August 6th. Morgan Stanley raised their target price on shares of Delek US from $41.00 to $45.00 and gave the stock an “equal weight” rating in a report on Friday, June 12th. The Goldman Sachs Group lifted their target price on shares of Delek US from $73.00 to $83.00 and gave the stock a “buy” rating in a research report on Tuesday, August 18th. Finally, Wells Fargo & Company boosted their price target on shares of Delek US from $59.00 to $82.00 and gave the company an “overweight” rating in a report on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat.com, Delek US presently has a consensus rating of “Moderate Buy” and an average price target of $59.09.
Read Our Latest Research Report on DK
Delek US Profile
Delek US Holdings, Inc (NYSE: DK) is an independent downstream energy company engaged in the refining, logistics, and marketing of petroleum products. Headquartered in Brentwood, Tennessee, the company operates a network of inland refineries, storage terminals and pipelines, and convenience store locations. Delek US focuses on converting crude oil into a variety of finished products, including gasoline, diesel, jet fuel, asphalt and renewable fuels, serving wholesale and retail customers across the United States.
In its refining segment, Delek US owns and operates four inland refineries located in Texas and Arkansas.
Further Reading
- Five stocks we like better than Delek US
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Want to see what other hedge funds are holding DK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Delek US Holdings, Inc. (NYSE:DK – Free Report).
Receive News & Ratings for Delek US Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delek US and related companies with MarketBeat.com's FREE daily email newsletter.
